Impact of concomitant aortic stenosis on the management and outcomes of acute myocardial infarction hospitalizations in the United States.

Acute myocardial infarction Aortic stenosis Geriatric cardiology Mortality Outcomes research

Journal

American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333

Informations de publication

Date de publication:
Nov 2022
Historique:
entrez: 21 11 2022
pubmed: 22 11 2022
medline: 22 11 2022
Statut: ppublish

Résumé

To evaluate the prevalence, management and outcomes of concomitant aortic stenosis (AS) in admissions with acute myocardial infarction (AMI). We used the HCUP-NIS database (2000-2017) to identify adult AMI admissions with concomitant AS. Outcomes of interest included prevalence of AS, in-hospital mortality, use of cardiac procedures, hospitalization costs, length of stay, and discharge disposition. Among a total of 11,622,528 AMI admissions, 513,688 (4.4 %) were identified with concomitant AS. Adjusted temporal trends revealed an increase in STEMI and NSTEMI hospitalizations with concomitant AS. Compared to admissions without AS, those with AS were on average older, of female sex, had higher comorbidity, higher rates of NSTEMI (78.9 % vs 62.1 %), acute non-cardiac organ failure, and cardiogenic shock. Concomitant AS was associated with significantly lower use of coronary angiography (45.5 % vs 64.4 %), percutaneous coronary intervention (20.1 % vs 42.5 %), coronary atherectomy (1.7 % vs. 2.8 %) and mechanical circulatory support (3.5 % vs 4.8 %) (all In this 18-year study, an increase in prevalence of AS in AMI hospitalization was noted. Concomitant AS was associated with lower use of guideline-directed therapies and worse clinical outcomes among AMI admissions.

Identifiants

pubmed: 36404945
doi: 10.1016/j.ahjo.2022.100217
pmc: PMC9673464
mid: NIHMS1848633
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Ann Thorac Surg. 2010 Mar;89(3):758-67; discussion 767
pubmed: 20172123
Am J Cardiol. 2002 Sep 1;90(5):551-4
pubmed: 12208424
J Gen Intern Med. 2011 Oct;26(10):1145-51
pubmed: 21573881
Eur Heart J. 2003 Apr;24(7):623-9
pubmed: 12657220
Catheter Cardiovasc Interv. 2018 Apr 1;91(5):932-937
pubmed: 28941139
J Gen Intern Med. 2007 Jul;22(7):982-7
pubmed: 17483977
Eur Heart J. 2014 Aug 14;35(31):2069-82
pubmed: 24970334
J Am Coll Cardiol. 2013 Jul 2;62(1):1-10
pubmed: 23644089
J Am Heart Assoc. 2017 Feb 20;6(2):
pubmed: 28219922
Mayo Clin Proc Innov Qual Outcomes. 2020 Jun 12;4(4):362-372
pubmed: 32793864
Am J Cardiol. 1998 Mar 1;81(5):647-9
pubmed: 9514469
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):
pubmed: 28705865
J Am Heart Assoc. 2014 May 28;3(3):e000879
pubmed: 24870936
J Am Heart Assoc. 2017 Sep 21;6(9):
pubmed: 28935681
Am J Cardiol. 2001 May 15;87(10):1216-7; A7
pubmed: 11356405
Am J Cardiol. 2021 Jul 1;150:1-7
pubmed: 34001337
Am J Cardiol. 2021 Aug 15;153:30-35
pubmed: 34167785
J Am Coll Cardiol. 2021 Jul 13;78(2):195-197
pubmed: 33989712
Am J Cardiol. 2016 Feb 15;117(4):555-562
pubmed: 26732421
J Invasive Cardiol. 2020 May;32(5):E110-E121
pubmed: 32357132
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Am J Cardiol. 2020 Oct 15;133:32-38
pubmed: 32807388
Atherosclerosis. 2009 Jun;204(2):e103-8
pubmed: 19171341
Intern Med J. 2021 Mar;51(3):319-326
pubmed: 31908088
Can J Cardiol. 2020 Jul;36(7):1104-1111
pubmed: 32479749
J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791
pubmed: 30975295
J Am Heart Assoc. 2021 Aug 3;10(15):e020517
pubmed: 33998286
Int J Cardiol. 2013 Oct 3;168(3):2528-32
pubmed: 23628298

Auteurs

Sri Harsha Patlolla (SH)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States of America.

Muhammad Haisum Maqsood (MH)

Department of Medicine, Lincoln Medical Center, The Bronx, NY, United States of America.

P Matthew Belford (PM)

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America.

Arnav Kumar (A)

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.

Alexander G Truesdell (AG)

Virginia Heart/Inova Heart and Vascular Institute, Falls Church, VA, United States of America.

Pinak B Shah (PB)

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.

Mandeep Singh (M)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.

David R Holmes (DR)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.

David X Zhao (DX)

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America.

Saraschandra Vallabhajosyula (S)

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America.

Classifications MeSH